RXFP1 is targeted by complement C1q Tumor Necrosis Factor-related factor 8 (CTRP8) in brain cancer

15Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The relaxin-like - RXFP1 ligand-receptor system has important functions in tumor growth and tissue invasion. Recently, we have identified the secreted protein, CTRP8, a member of the C1q/ Tumor Necrosis Factor-related protein (CTRP) family, as a novel ligand of the relaxin receptor RXFP1 with functions in brain cancer. Here we review the role of CTRP members in cancers cells with particular emphasis on CTRP8 in glioblastoma.

Cite

CITATION STYLE

APA

Thanasupawat, T., Glogowska, A., Burg, M., Wong, G. W., Hoang-Vu, C., Hombach-Klonisch, S., & Klonisch, T. (2015). RXFP1 is targeted by complement C1q Tumor Necrosis Factor-related factor 8 (CTRP8) in brain cancer. Frontiers in Endocrinology, 6(JUL). https://doi.org/10.3389/fendo.2015.00127

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free